These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23059542)

  • 1. Novel pyrimidopyrimidine derivatives for inhibition of cellular proliferation and motility induced by h-prune in breast cancer.
    Virgilio A; Spano D; Esposito V; Di Dato V; Citarella G; Marino N; Maffia V; De Martino D; De Antonellis P; Galeone A; Zollo M
    Eur J Med Chem; 2012 Nov; 57():41-50. PubMed ID: 23059542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. h-prune affects anaplastic thyroid cancer invasion and metastasis.
    Nambu J; Kobayashi T; Hashimoto M; Tashiro H; Sugino K; Shimamoto F; Kikuchi A; Ohdan H
    Oncol Rep; 2016 Jun; 35(6):3445-52. PubMed ID: 27109060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding h-prune biology in the fight against cancer.
    Marino N; Zollo M
    Clin Exp Metastasis; 2007; 24(8):637-45. PubMed ID: 17952613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis.
    D'Angelo A; Garzia L; André A; Carotenuto P; Aglio V; Guardiola O; Arrigoni G; Cossu A; Palmieri G; Aravind L; Zollo M
    Cancer Cell; 2004 Feb; 5(2):137-49. PubMed ID: 14998490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domain mapping on the human metastasis regulator protein h-Prune reveals a C-terminal dimerization domain.
    Middelhaufe S; Garzia L; Ohndorf UM; Kachholz B; Zollo M; Steegborn C
    Biochem J; 2007 Oct; 407(2):199-205. PubMed ID: 17655525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
    Souness JE; Diocee BK; Martin W; Moodie SA
    Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling genes and pathways influenced by H-prune PDE overexpression: a model to study cellular motility.
    D'Angelo A; Zollo M
    Cell Cycle; 2004 Jun; 3(6):758-61. PubMed ID: 15254413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching for cellular targets of novel pteridines downstream of cAMP PDE inhibition.
    Vatter S; Merz KH; Eisenbrand G
    Int J Clin Pharmacol Ther; 2005 Dec; 43(12):607-8. PubMed ID: 16372537
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities.
    Lugnier C; Gauthier C; Le Bec A; Soustre H
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H654-60. PubMed ID: 1373036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cAMP analogs and selective inhibitors used to study low Km Mucor rouxii cAMP phosphodiesterase.
    Tomes C; Moreno S
    Int J Biochem; 1990; 22(9):1047-51. PubMed ID: 1704316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fused pyrimidine based inhibitors of phosphodiesterase 7 (PDE7): synthesis and initial structure-activity relationships.
    Kempson J; Pitts WJ; Barbosa J; Guo J; Omotoso O; Watson A; Stebbins K; Starling GC; Dodd JH; Barrish JC; Felix R; Fischer K
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1829-33. PubMed ID: 15780616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. h-Prune is associated with poor prognosis and epithelial-mesenchymal transition in patients with colorectal liver metastases.
    Hashimoto M; Kobayashi T; Tashiro H; Arihiro K; Kikuchi A; Ohdan H
    Int J Cancer; 2016 Aug; 139(4):812-23. PubMed ID: 27037526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrrolo[2,3-d]pyrimidines as inhibitors of cAMP-phosphodiesterase. Structure-activity relationship.
    Klumpp S; Frey M; Kleefeld G; Sauer A; Eger K
    Biochem Pharmacol; 1989 Mar; 38(6):949-53. PubMed ID: 2539163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors.
    Foudah AI; Sallam AA; Akl MR; El Sayed KA
    Eur J Med Chem; 2014 Feb; 73():310-24. PubMed ID: 24487236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
    Lugnier C; Schini VB
    Biochem Pharmacol; 1990 Jan; 39(1):75-84. PubMed ID: 2153383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of plasma adenosine in the antiplatelet action of HL 725, a potent inhibitor of cAMP phosphodiesterase: species differences.
    Agarwal KC; Buckley RS; Parks RE
    Thromb Res; 1987 Jul; 47(2):191-200. PubMed ID: 2821650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of nm23-H1 by CKI induces its complex formation with h-prune and promotes cell motility.
    Garzia L; D'Angelo A; Amoresano A; Knauer SK; Cirulli C; Campanella C; Stauber RH; Steegborn C; Iolascon A; Zollo M
    Oncogene; 2008 Mar; 27(13):1853-64. PubMed ID: 17906697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic studies on selective type 4 phosphodiesterase (PDE 4) inhibitors. 1. Structure-activity relationships and pharmacological evaluation of 1,8-naphthyridin-2(1H)-one derivatives.
    Takayama K; Iwata M; Hisamichi H; Okamoto Y; Aoki M; Niwa A
    Chem Pharm Bull (Tokyo); 2002 Aug; 50(8):1050-9. PubMed ID: 12192136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
    Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
    Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.